MedTrace Logo

Efficacy of Dexpanthenol in Thermic Erythema

NCT00839462 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2013-10-21

No results posted yet for this study

Summary

The study focuses to prove the equivalent efficacy of two different Dexpanthenol formulations.

Conditions

  • Erythema

Interventions

DRUG

Dexpanthenol foam spray, new formulation

2 applications of 2 micro liter/square centimeter on a 4X4 cm area corresponding to 32 micro liter

DRUG

Dexpanthenol foam spray, old formulation

2 applications of 2 micro liter/square centimeter on a 4X4 cm area corresponding to 32 micro liter

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2007-09-30
Completion
2007-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00839462 on ClinicalTrials.gov